Interestingly, ex vivo analysis of MOC2-CIITA tumor growing in vivo showed a clear reduction of MHC-II expression, thus strongly correlating anti-tumor capacity to respond in vivo to the amount of CIITA-dependent MHC-II expression. The gene discussed is CIITA; the disease is neoplasm.